Profound Medical PROF Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Capital Equipment | $2.86M-22.1% | $3.68M+200% | $1.22M+88.2% | $650K-20.7% | $820K-44.9% | |
| Recurring Non Capital | $2.47M+7.5% | $2.3M-43.4% | $4.07M+160% | $1.56M-13.3% | $1.8M-33.0% | |
| Revenue by Geography | ||||||
| CA | $3.57M+77.2% | $2.02M+1,593% | $119K+26.6% | $94K-89.0% | $852K-25.6% | |
| DE | $150K-37.2% | $239K+42.3% | $168K+20.0% | $140K-38.1% | $226K+48.7% | |
| US | $1.62M-56.6% | $3.72M-25.6% | $5M+153% | $1.98M+28.1% | $1.54M-46.4% | |
| Total Assets by Geography | ||||||
| CA | $61.45M-2.5% | $63.05M+137% | $26.6M-30.3% | $38.18M-23.5% | $49.91M-15.0% | |
| CN | $108K-21.2% | $137K+37.0% | $100K+66.7% | $60K-47.8% | $115K+25.0% | |
| DE | $1.16M-6.9% | $1.24M-7.3% | $1.34M-10.7% | $1.5M-17.2% | $1.82M+9.3% | |
| FI | $3.35M+2.8% | $3.26M-3.3% | $3.37M+7.9% | $3.12M+13.2% | $2.76M-18.5% | |
| US | $7.39M-24.5% | $9.79M-10.1% | $10.89M+60.1% | $6.8M+8.6% | $6.27M-1.4% | |
| PP&E (Net) by Geography | ||||||
| CA | $27K-34.1% | $41K-24.1% | $54K-21.7% | $69K-12.7% | $79K-15.1% | |
| FI | $164K-6.8% | $176K— | —— | —— | —— | |
| US | $491K+2.1% | $481K+69.4% | $284K+35.9% | $209K-9.1% | $230K-30.7% | |
| Depreciation by Geography | ||||||
| CA | $15K+25.0% | $12K-25.0% | $16K+60.0% | $10K-23.1% | $13K-21.2% | |
| FI | $12K— | —— | —— | —— | —— | |
| US | $66K+32.0% | $50K-35.1% | $77K-16.3% | $92K-10.7% | $103K-35.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Profound Medical break its business down?
- Profound Medical (PROF) reports revenue by product across 2 parts — Capital Equipment and Recurring Non Capital. Each is extracted from the segment footnotes and tracked over time.
- Where does Profound Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Profound Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
